Top compounds associated with response to IER5L


Feature Type Standardized
Nominal ANOVA
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.028 0.5
mRNA AG-014699 GDSC1000 pan-cancer AAC 0.027 0.5
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA necrostatin-1 CTRPv2 pan-cancer AAC -0.027 0.5
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC -0.028 0.5
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.036 0.5
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.034 0.5
mRNA EX-527 CTRPv2 pan-cancer AAC -0.028 0.5
Download CSV